Researchers in a peer-reviewed review of bremelanotide note that it is a melanocortinergic agent studied for female sexual function, which is why it broadens the conversation beyond blood-flow-based options
van Ruiten CC, Smits MM, Kok MD, et al
Improved Blood Flow and Oxygen Delivery: BPC-157 promotes angiogenesis, the formation of new blood vessels
February 2024 Ozempic Update On February 2, 2024, the Judicial Panel on Multidistrict Litigation ordered that all Ozempic, and other GLP-1 medication cases, be consolidated in the United States District Court for the Eastern District of Pennsylvania
In some embodiments, the otic formulation or composition comprises between about 0.01% to about 3% by weight of the therapeutic agent, or pharmaceutically acceptable prodrug or salt thereof
In the phase II trial, CagriSema has similar efficacy to tirzepatide.